Global Microbiome Based Drugs Market Status and Forecast 2021-2027
This report provides a comprehensive analysis of current global Microbiome Based Drugs market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Microbiome Based Drugs industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to this survey, the global Microbiome Based Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Microbiome Based Drugs Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Microbiome Based Drugs market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Microbiome Based Drugs Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Microbiome Based Drugs industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Oral Dosage Form
Enteric Capsules
Segmented by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Symberix
Seres Therapeutics
Second Genome
Ritter Pharmaceuticals
Rebiotix
PureTech
Osel
OpenBiome
Metabiomics
Interxon
Enterome BioScience
Azitra
Assembly Biosciences
AOBiome
4D Pharma
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Microbiome Based Drugs Market Status and Forecast (2016-2027)
1.3.2 Global Microbiome Based Drugs Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Microbiome Based Drugs Supply by Company
2.1 Global Microbiome Based Drugs Sales Volume by Company
2.2 Global Microbiome Based Drugs Sales Value by Company
2.3 Global Microbiome Based Drugs Price by Company
2.4 Microbiome Based Drugs Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Microbiome Based Drugs Market Status by Type
3.1 Microbiome Based Drugs Type Introduction
3.1.1 Oral Dosage Form
3.1.2 Enteric Capsules
3.2 Global Microbiome Based Drugs Market by Type
3.2.1 Global Microbiome Based Drugs Sales Volume by Type (2016-2021)
3.2.2 Global Microbiome Based Drugs Sales Value by Type (2016-2021)
3.2.3 Global Microbiome Based Drugs Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Microbiome Based Drugs Market Status by Application
4.1 Microbiome Based Drugs Segment by Application
4.1.1 Gastrointestinal Disorders
4.1.2 Autoimmune Disorders
4.1.3 Diabetes
4.1.4 Cancer
4.2 Global Microbiome Based Drugs Market by Application
4.2.1 Global Microbiome Based Drugs Sales Volume by Application (2016-2021)
4.2.2 Global Microbiome Based Drugs Sales Value by Application (2016-2021)
4.2.3 Global Microbiome Based Drugs Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Microbiome Based Drugs Market Status by Region
5.1 Global Microbiome Based Drugs Market by Region
5.1.1 Global Microbiome Based Drugs Sales Volume by Region
5.1.2 Global Microbiome Based Drugs Sales Value by Region
5.2 North America Microbiome Based Drugs Market Status
5.3 Europe Microbiome Based Drugs Market Status
5.4 Asia Pacific Microbiome Based Drugs Market Status
5.5 Central & South America Microbiome Based Drugs Market Status
5.6 Middle East & Africa Microbiome Based Drugs Market Status
6 North America Microbiome Based Drugs Market Status
6.1 North America Microbiome Based Drugs Market by Country
6.1.1 North America Microbiome Based Drugs Sales Volume by Country (2016-2021)
6.1.2 North America Microbiome Based Drugs Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Microbiome Based Drugs Market Status
7.1 Europe Microbiome Based Drugs Market by Country
7.1.1 Europe Microbiome Based Drugs Sales Volume by Country (2016-2021)
7.1.2 Europe Microbiome Based Drugs Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Microbiome Based Drugs Market Status
8.1 Asia Pacific Microbiome Based Drugs Market by Country
8.1.1 Asia Pacific Microbiome Based Drugs Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Microbiome Based Drugs Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Microbiome Based Drugs Market Status
9.1 Central & South America Microbiome Based Drugs Market by Country
9.1.1 Central & South America Microbiome Based Drugs Sales Volume by Country (2016-2021)
9.1.2 Central & South America Microbiome Based Drugs Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Microbiome Based Drugs Market Status
10.1 Middle East & Africa Microbiome Based Drugs Market by Country
10.1.1 Middle East & Africa Microbiome Based Drugs Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Microbiome Based Drugs Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Microbiome Based Drugs Manufacturing Cost Analysis
11.5 Microbiome Based Drugs Sales Channel and Distributors Analysis
11.5.1 Microbiome Based Drugs Sales Channel
11.5.2 Microbiome Based Drugs Distributors
11.6 Microbiome Based Drugs Downstream Major Buyers
12 Global Microbiome Based Drugs Market Forecast by Type and by Application
12.1 Global Microbiome Based Drugs Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Microbiome Based Drugs Forecast by Type
12.2.1 Global Microbiome Based Drugs Sales Volume Forecast by Type
12.2.2 Global Microbiome Based Drugs Sales Value Forecast by Type
12.2.3 Global Microbiome Based Drugs Price Forecast by Type
12.3 Global Microbiome Based Drugs Forecast by Application
12.3.1 Global Microbiome Based Drugs Sales Volume Forecast by Application
12.3.2 Global Microbiome Based Drugs Sales Value Forecast by Application
12.3.3 Global Microbiome Based Drugs Price Forecast by Application
13 Global Microbiome Based Drugs Market Forecast by Region/Country
13.1 Global Microbiome Based Drugs Market Forecast by Region (2022-2027)
13.1.1 Global Microbiome Based Drugs Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Microbiome Based Drugs Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Synthetic Biologics
14.1.1 Company Information
14.1.2 Microbiome Based Drugs Product Introduction
14.1.3 Synthetic Biologics Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Synlogic
14.2.1 Company Information
14.2.2 Microbiome Based Drugs Product Introduction
14.2.3 Synlogic Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Symberix
14.3.1 Company Information
14.3.2 Microbiome Based Drugs Product Introduction
14.3.3 Symberix Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Seres Therapeutics
14.4.1 Company Information
14.4.2 Microbiome Based Drugs Product Introduction
14.4.3 Seres Therapeutics Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Second Genome
14.5.1 Company Information
14.5.2 Microbiome Based Drugs Product Introduction
14.5.3 Second Genome Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Ritter Pharmaceuticals
14.6.1 Company Information
14.6.2 Microbiome Based Drugs Product Introduction
14.6.3 Ritter Pharmaceuticals Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Rebiotix
14.7.1 Company Information
14.7.2 Microbiome Based Drugs Product Introduction
14.7.3 Rebiotix Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 PureTech
14.8.1 Company Information
14.8.2 Microbiome Based Drugs Product Introduction
14.8.3 PureTech Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Osel
14.9.1 Company Information
14.9.2 Microbiome Based Drugs Product Introduction
14.9.3 Osel Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 OpenBiome
14.10.1 Company Information
14.10.2 Microbiome Based Drugs Product Introduction
14.10.3 OpenBiome Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 Metabiomics
14.12 Interxon
14.13 Enterome BioScience
14.14 Azitra
14.15 Assembly Biosciences
14.16 AOBiome
14.17 4D Pharma
15 Conclusion
16 Methodology
Tables and Figures
List of Tables
Table Global Microbiome Based Drugs Sales Value and CAGR by Region (2016-2027)
Table Global Microbiome Based Drugs Sales Volume by Company (2019-2021)
Table Global Microbiome Based Drugs Sales Volume Market Share by Company (2019-2021)
Table Global Microbiome Based Drugs Sales Value by Company (2019-2021)
Table Global Microbiome Based Drugs Sales Value and CAGR by Region (2016-2027)
Table Global Microbiome Based Drugs Price by Company (2019-2021)
Table Main Manufacturers Microbiome Based Drugs Product Location and Sales Area
Table Global Microbiome Based Drugs Sales Value by Company (2019-2021)
Table Global Microbiome Based Drugs Sales Volume by Type (2016-2021)
Table Global Microbiome Based Drugs Sales Volume Market Share by Type (2016-2021)
Table Global Microbiome Based Drugs Sales Value by Type (2016-2021)
Table Global Microbiome Based Drugs Sals Value Market Share by Type (2016-2021)
Table Global Microbiome Based Drugs Price by Type (2016-2021)
Table North America Microbiome Based Drugs Sales Volume by Type (2016-2021)
Table Global Microbiome Based Drugs Sales Value by Type (2016-2021)
Table Europe Microbiome Based Drugs Sales Volume by Type (2016-2021)
Table Europe Microbiome Based Drugs Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Microbiome Based Drugs Sales Volume by Type (2016-2021)
Table Asia Pacific Microbiome Based Drugs Sales Volume Market Share by Type (2016-2021)
Table Central & South America Microbiome Based Drugs Sales Volume by Type (2016-2021)
Table Central & South America Pacific Microbiome Based Drugs Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Microbiome Based Drugs Sales Volume by Type (2016-2021)
Table Middle East & Africa Microbiome Based Drugs Sales Volume Market Share by Type (2016-2021)
Table Global Microbiome Based Drugs Sales Volume by Application (2016-2021)
Table Global Microbiome Based Drugs Sales Volume Market Share by Application (2016-2021)
Table Global Microbiome Based Drugs Sales Value by Application (2016-2021)
Table Global Microbiome Based Drugs Value Market Share by Application (2016-2021)
Table Global Microbiome Based Drugs Price by Application (2016-2021)
Table North America Microbiome Based Drugs Sales Volume by Application (2016-2021)
Table Global Microbiome Based Drugs Sales Value by Application (2016-2021)
Table Europe Microbiome Based Drugs Sales Volume by Application (2016-2021)
Table Europe Microbiome Based Drugs Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Microbiome Based Drugs Sales Volume by Application (2016-2021)
Table Asia Pacific Microbiome Based Drugs Sales Volume Market Share by Application (2016-2021)
Table Central & South America Microbiome Based Drugs Sales Volume by Application (2016-2021)
Table Central & South America Pacific Microbiome Based Drugs Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Microbiome Based Drugs Sales Volume by Application (2016-2021)
Table Middle East & Africa Microbiome Based Drugs Sales Volume Market Share by Application (2016-2021)
Table Global Microbiome Based Drugs Sales Volume by Region (2016-2021)
Table Global Microbiome Based Drugs Sales Volume Market Share by Region (2016-2021)
Table Global Microbiome Based Drugs Sales Value by Region (2016-2021)
Table Global Microbiome Based Drugs Value Market Share by Region (2016-2021)
Table North America Microbiome Based Drugs Sales Volume by Country (2016-2021)
Table North America Microbiome Based Drugs Sales Volume Market Share by Country (2016-2021)
Table Global Microbiome Based Drugs Sales Value by Region/Country (2016-2021)
Table North America Microbiome Based Drugs Value Market Share by Country (2016-2021)
Table Europe Microbiome Based Drugs Sales Volume by Country (2016-2021)
Table Europe Microbiome Based Drugs Sales Volume Market Share by Country (2016-2021)
Table Europe Microbiome Based Drugs Sales Value by Country (2016-2021)
Table Europe Microbiome Based Drugs Value Market Share by Country (2016-2021)
Table Asia Pacific Microbiome Based Drugs Sales Volume by Country (2016-2021)
Table Asia Pacific Microbiome Based Drugs Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Microbiome Based Drugs Sales Value by Country (2016-2021)
Table Asia Pacific Microbiome Based Drugs Value Market Share by Country (2016-2021)
Table Central & South America Microbiome Based Drugs Sales Volume by Country (2016-2021)
Table Central & South America Microbiome Based Drugs Sales Volume Market Share by Country (2016-2021)
Table Central & South America Microbiome Based Drugs Sales Value by Country (2016-2021)
Table Central & South America Microbiome Based Drugs Value Market Share by Country (2016-2021)
Table Middle East & Africa Microbiome Based Drugs Sales Volume by Country (2016-2021)
Table Middle East & Africa Microbiome Based Drugs Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Microbiome Based Drugs Sales Value by Country (2016-2021)
Table Middle East & Africa Microbiome Based Drugs Value Market Share by Country (2016-2021)
Table Microbiome Based Drugs Raw Materials Key Suppliers List
Table Microbiome Based Drugs Distributors List
Table Microbiome Based Drugs Buyers List
Table Global Microbiome Based Drugs Sales Volume Forecast by Type (2022-2027)
Table Global Microbiome Based Drugs Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Microbiome Based Drugs Value Forecast by Type (2022-2027)
Table Global Microbiome Based Drugs Value Market Share Forecast by Type (2022-2027)
Table Global Microbiome Based Drugs Price Forecast by Type (2022-2027)
Table Global Microbiome Based Drugs Sales Volume Forecast by Application (2022-2027)
Table Global Microbiome Based Drugs Value Forecast by Type (2022-2027)
Table Global Microbiome Based Drugs Value Forecast by Application (2022-2027)
Table Global Microbiome Based Drugs Value Market Share Forecast by Application (2022-2027)
Table Global Microbiome Based Drugs Price Forecast by Application (2022-2027)
Table Global Microbiome Based Drugs Sales Volume Forecast by Region (2022-2027)
Table Global Microbiome Based Drugs Value Forecast by Application (2022-2027)
Table Global Microbiome Based Drugs Value Forecast by Region (2022-2027)
Table Global Microbiome Based Drugs Value Market Share Forecast by Region (2022-2027)
Table Synthetic Biologics Company Information
Table Synthetic Biologics Product Introduction
Table Global Microbiome Based Drugs Value Forecast by Region (2022-2027)
Table Synlogic Company Information
Table Synlogic Product Introduction
Table Synlogic Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Symberix Company Information
Table Symberix Product Introduction
Table Symberix Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Seres Therapeutics Company Information
Table Seres Therapeutics Product Introduction
Table Seres Therapeutics Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Second Genome Company Information
Table Second Genome Product Introduction
Table Second Genome Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Ritter Pharmaceuticals Company Information
Table Ritter Pharmaceuticals Product Introduction
Table Ritter Pharmaceuticals Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Rebiotix Company Information
Table Rebiotix Product Introduction
Table Rebiotix Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table PureTech Company Information
Table PureTech Product Introduction
Table PureTech Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Osel Company Information
Table Osel Product Introduction
Table Osel Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table OpenBiome Company Information
Table OpenBiome Product Introduction
Table OpenBiome Microbiome Based Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets